Project Grant 2431976
Award Date
5/15/25
Completion Date
4/30/27
Dollars Obligated
$550K
Federal Agency
National Science Foundation
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $591,844 to Allvivo Vascular, Inc. to develop a catheter end cap with an antimicrobial luminal insert. The goal is to reduce the risk of bloodstream infections in hemodialysis patients, which are a leading cause of hospitalization and death in this population. The project aims...
The National Science Foundation awarded a $249,884 Project Grant to the Regents of the University of Minnesota under the NSF Technology, Innovation, and Partnerships federal grant program (CFDA 47.084) to develop a decentralized, on-demand production system for large volume parenteral solutions and medical fluids. The University will implement a proof-of-concept prototype capable of producing 100 L/hr of solutions such as electrolyte replacement, intravenous fluids, and dialysis mixtures on-site...
The National Science Foundation (NSF) has awarded a $1,000,000 Cooperative Agreement under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to Aidar Health, Inc.'s Rapid Advantage Division. The purpose of this 2-year award is to develop a comprehensive remote health management system for patients with chronic kidney disease. Key deliverables include a medical device, digital tools with advanced analytics capabilities, and a novel patient engagement feature using...
This Project Grant award from the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships program) provides $274,274 to X-Cor Therapeutics Inc., a minority-owned small disadvantaged business in Washington, DC, to develop a novel respiratory dialysis system for treating chronic obstructive pulmonary disease (COPD) patients. The project aims to optimize a prototype that can efficiently remove excess carbon dioxide from the blood of COPD patients, with the goal of...
This federal Project Grant award, valued at $3,618,191.00 and issued on July 1, 2024, is funded by the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420). The award supports the development of a portable hemodialysis device to facilitate home use and field implementation. The primary awardee, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., will lead the research and development efforts. This includes optimizing a...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $312,088 to Sojourn Medtech LLC to develop the CANSIM simulator. The CANSIM is a smart, personalized, and dialysis-specific training device to teach critical cannulation skills to dialysis nurses and patient care technicians. The key features include: 1) dialysis-specific design, 2) realistic and low-maintenance...
The National Science Foundation Division of Industrial Innovation awarded The Johns Hopkins University a $550,000 Project Grant under the Engineering federal grant program (CFDA 47.041) from August 15, 2021 to July 31, 2024. The grant funds the development of a clinical decision support tool to identify patients diagnosed with heart failure who are at high risk of 30-day hospital readmission. The Engineering program seeks to improve quality of life and economic strength by fostering innovation...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award to Anvil Diagnostics Inc. in Cambridge, MA provides $298,646 to develop a rapid diagnostic test for detecting sepsis-causing pathogens in plasma samples. The proposed technology aims to comprehensively identify and quantify a wide range of pathogens from small blood volumes within 4 hours, addressing critical limitations of current sepsis diagnostics. The innovations focus on...
The National Science Foundation (NSF) awarded a three-year, $449,999 Project Grant under their Engineering program (CFDA 47.041) to the University of Cincinnati to develop an implantable biosensor platform that can continuously monitor various biomarkers in the body for over a year. The project aims to create a new class of long-lasting aptamer-based sensors protected by robust porous oxide coatings, which would enable the first practical implantable monitoring system for managing chronic...
This federal Project Grant award for $295,000 from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of an innovative, implantable device for treating diabetic foot ulcers. The awardee, Biodynamik, is designing and testing a low-profile, transverse tibial transport device that leverages distraction osteogenesis to stimulate soft tissue growth and restore blood circulation to the diseased limb, providing a new treatment...